e-learning
resources
ERJ
2005
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Smooth muscle cell matrix metalloproteinases in idiopathic pulmonary arterial hypertension
Lepetit H., Eddahibi S., Fadel E., Frisdal E., Munaut C., Noel A., Humbert M., Adnot S., D'Ortho M-P., Lafuma C.
Source:
Eur Respir J 2005; 25: 834-842
Journal Issue:
May
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Lepetit H., Eddahibi S., Fadel E., Frisdal E., Munaut C., Noel A., Humbert M., Adnot S., D'Ortho M-P., Lafuma C.. Smooth muscle cell matrix metalloproteinases in idiopathic pulmonary arterial hypertension. Eur Respir J 2005; 25: 834-842
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Special issues in elderly people with solitary pulmonary nodule: non intubated thoracic surgery
Transplantation pulmonaire à l’heure de la médecine de précision Lung transplantation in the era of precision medicine
Lung transplantation
Related content which might interest you:
Matrix metalloproteinases and their inhibitors in pulmonary hypertension},
Source: Eur Respir J 2012; 40: 766-782
Year: 2012
Extracellular matrix components and regulators in the airway smooth muscle in asthma
Source: Eur Respir J 2008; 32: 61-69
Year: 2008
Gelatinase expression in pulmonary arteries during experimental pulmonary hypertension
Source: Eur Respir J 2001; 18: 838-845
Year: 2001
Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF
Source: Eur Respir J 2002; 20: 1220-1227
Year: 2002
Role of matrix metalloproteinases in progression of idiopathic pulmonary fibrosis
Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease
Year: 2010
Effects of cyclic stretch on stiffness and matrix metalloproteinases (MMPs) in mouse lung tissue strips
Source: Annual Congress 2009 - Mechanisms of pulmonary inflammation and fibrosis
Year: 2009
Matrix metalloproteinases, as markers of the severity of idiopathic pulmonary fibrosis
Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia
Year: 2019
Matrix metalloproteinases in pulmonary fibrosis
Source: Annual Congress 2013 –Regulation of lung inflammation and repair by proteolysis
Year: 2013
Pathobiology of pulmonary arterial hypertension
Source: Eur Respir J 2002; 20: 1559-1572
Year: 2002
Role of endothelin in lung fibrosis
Source: Eur Respir Rev 2008; 17: 145-150
Year: 2008
The role of matrix metalloproteinase- 9 (MMP-9) and tissue inhibitor of matrix metalloproteinase-1 (TIMMP-1) in sarcoidosis and idiopathic pulmonary fibrosis. Correlation with echocardiography
Source: Eur Respir J 2006; 28: Suppl. 50, 745s
Year: 2006
Matrix metalloproteinases (MMPs) and angiogenesis in lung tissue remodeling in different variants of idiopathic interstitial pneumonia (IIP)
Source: Eur Respir J 2007; 30: Suppl. 51, 137s
Year: 2007
Metalloproteinases in idiopathic pulmonary fibrosis
Source: Eur Respir J 2011; 38: 1461-1467
Year: 2011
Regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases expression in the bronchial secretions of asthmatics and COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 92s
Year: 2002
MMP expression and abnormal lung permeability are important determinants of outcome in IPF
Source: Eur Respir J 2009; 33: 77-84
Year: 2009
Effects of neurotrophins on matrix metalloproteinase production in human bronchial smooth muscle cells
Source: Eur Respir J 2005; 26: Suppl. 49, 128s
Year: 2005
Statins inhibit matrix metalloproteinase release from human lung fibroblasts
Source: Eur Respir J 2010; 35: 637-646
Year: 2010
Matrix metalloproteinase (MMP)-2 production by fibroblasts and mast cells: the role in pulmonary fibrosis
Source: Eur Respir J 2004; 24: Suppl. 48, 455s
Year: 2004
Matrix metalloproteinases in COPD
Source: Eur Respir J 2012; 39: 197-209
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept